tiprankstipranks
EKSO BIONICS (EKSO)
NASDAQ:EKSO

EKSO BIONICS (EKSO) Income Statement

509 Followers

EKSO BIONICS Income Statement

Last quarter (Q4 2023), EKSO BIONICS's total revenue was $4.85M, an increase of 36.50% from the same quarter last year. In Q4, EKSO BIONICS's net income was $-3.21M. See EKSO BIONICS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 14.16M$ 18.28M$ 12.91M$ 11.25M$ 8.88M$ 13.92M
Cost of Revenue
$ 9.20M$ 9.20M$ 6.70M$ -4.50M$ 3.81M$ 7.15M
Gross Profit
$ 4.96M$ 9.08M$ 6.21M$ 6.75M$ 5.07M$ 6.76M
Operating Expense
$ 24.19M$ 24.19M$ 21.77M$ -20.58M$ 17.93M$ 23.40M
Operating Income
$ -19.23M$ -15.11M$ -15.56M$ -25.07M$ -12.86M$ -16.64M
Net Non Operating Interest Income Expense
$ -328.00K$ -302.00K$ -156.00K$ 4.95M$ -139.00K$ -1.48M
Other Income Expense
$ -3.95M$ 196.00K$ -1.29M$ -10.36M$ -2.83M$ 5.99M
Pretax Income
$ -15.20M$ -15.20M$ -15.08M$ -9.76M$ -15.82M$ -12.13M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -15.20M$ -15.20M$ -15.08M$ -9.76M$ -15.82M$ -12.13M
Basic EPS
$ -1.10$ -1.10$ -1.16$ -0.80$ -2.21$ -2.55
Diluted EPS
$ -1.10$ -1.10$ -1.16$ -0.88$ -2.21$ -2.55
Basic Average Shares
$ 55.47M$ 13.87M$ 12.96M$ 12.19M$ 7.16M$ 4.79M
Diluted Average Shares
$ 55.47M$ 13.87M$ 12.96M$ 12.27M$ 7.16M$ 4.79M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 33.39M$ 33.39M$ 28.47M$ -25.07M$ 21.74M$ 30.56M
Net Income From Continuing And Discontinued Operation
$ -15.20M$ -15.20M$ -15.08M$ -9.76M$ -15.82M$ -12.13M
Normalized Income
$ -6.15M-$ -11.91M-$ -12.01M$ -18.25M
Interest Expense
----$ 139.00K$ 384.00K
EBIT
$ -14.88M$ -14.90M$ -14.92M$ -9.65M$ -15.69M$ -11.75M
EBITDA
$ -12.94M$ -13.20M$ -14.04M$ -9.09M$ -15.07M$ -11.06M
Currency in USD

EKSO BIONICS Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis